Fig. 1From: Platelet count as a biomarker for monitoring treatment response and disease recurrence in recurrent epithelial ovarian cancerCumulative survival curves for PFS and OS according to pretreatment platelet count and the reduction of platelet count by Kaplan-Meier method in the 104 patients with recurrent EOC. a Progression free survival for pretreatment platelet count (P = 0.003); b Overall survival for pretreatment platelet count (P = 0.009); c Progression free survival for the reduction of platelet count (P = 0.021); d Overall survival for the reduction of platelet count (P = 0.009)Back to article page